Top Markets
Coin of the day
Mediwelcome Healthcare Management & Technology Inc. Mediwelcome Healthcare Management & Technology Inc.

Mediwelcome Healthcare Management & Technology Inc.

2159
Peringkat dalam Saham #24424
As an investment holding entity, Mediwelcome Healthcare Management & Technology... As an investment holding entity, Mediwelcome Healthcare Management & Technology Inc. delivers comprehensive marketing solutions for the healthcare sector within the People's Republic of China. Its service portfolio encompasses medical conference organization, patient education and screening programs, along with strategic marketing and advisory support. Additionally, the company provides Contract Research Organization (CRO) services, specifically focusing on patient recruitment and clinical data gathering. Furthermore, Mediwelcome manages a mobile application that facilitates internet hospital functionalities, including virtual follow-up consultations for physicians' current patients and electronic prescription services. Its diverse client base includes pharmaceutical firms, medical associations, and various foundations. Established in 2000, Mediwelcome Healthcare Management & Technology Inc. maintains its headquarters in Beijing, China.
Harga Saham
$0.2238709
Kapitalisasi Pasar
$60.77M
Perubahan (1 hari)
-3.31%
Perubahan (1 tahun)
10.72%
Negara
CN
Perdagangan Mediwelcome Healthcare Management & Technology Inc. (2159)

Kategori

Laba untuk Mediwelcome Healthcare Management & Technology Inc. (2159)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Mediwelcome Healthcare Management & Technology Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Mediwelcome Healthcare Management & Technology Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing